Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

ClinicalTrials.gov ID: NCT03199963

Public ClinicalTrials.gov record NCT03199963. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women With BI-RADS Breast Density Categories C or D

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A study to determine the efficacy of 8 mg/day (4 mg/breast) of BHR-700 gel compared to placebo for reducing breast tissue density in women identified as having dense breast tissue upon analysis of screening mammography. The Primary Study Endpoint being the percent reduction of mammographic breast tissue density on a follow-up mammogram compared to the baseline mammogram after 52 weeks of treatment.

Study identification

NCT ID
NCT03199963
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
BHR Pharma, LLC
Industry
Enrollment
223 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 21, 2017 (Actual)
Primary completion
Jan 14, 2019 (Actual)
Completion
Apr 23, 2019 (Actual)
Last update posted
Jul 26, 2022

2017 – 2019

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
Mesa Obstetricians and Gynecologists/Cactus Clinical Research Mesa Arizona 85209 —
Visions Clinical Research Tucson Arizona 85712 —
United Clinical Research Beverly Hills California 90211 —
City of Hope Duarte California 91010 —
USC-Keck Medical Center Los Angeles California 90033 —
South Florida Medical Research Aventura Florida 33180 —
Lake OB-GYN Associates of Mid-Florida Leesburg Florida 34748 —
Physician Care Clinical Research, LLC Sarasota Florida 34239 —
Affiliated Clinical Research, Inc. Las Vegas Nevada 89113 —
Center for Women's Health and Wellness Plainsboro New Jersey 08536 —
Bosque Women Care/Cactus Clinical Research Albuquerque New Mexico 87109 —
Carolina Women's Research and Wellness Center Durham North Carolina 27713 —
Aventiv Research, Inc. Columbus Ohio 43213 —
Coastal Carolina Research Center, Inc. Mt. Pleasant South Carolina 29464 —
University of Virginia Medical Park Northridge Charlottesville Virginia 22903 —
Overlake Internal Medicine Associates, PS Bellevue Washington 98004 —
Dedicated Women's Health Specialists Puyallup Washington 98372 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03199963, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2022 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03199963 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →